Annamária Simó

Title: Annamária Simó: Innovator in Pharmaceutical Chemistry

Introduction

Annamária Simó is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work focuses on creating innovative solutions for medical challenges.

Latest Patents

Annamária Simó holds a patent for a compound titled "8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as AMPA/kainate receptor inhibitors." This patent describes a novel 8-substituted-9H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine compound and its pharmaceutically acceptable quaternary ammonium salts. The patent outlines a process for preparing these compounds, a pharmaceutical composition containing them, and a method of treatment using the composition. The compounds possess unique competitive AMPA/kainate antagonist properties, making them useful in treating diseases where inhibition of the AMPA/kainate receptors may have a favorable effect. Annamária Simó has 1 patent to his name.

Career Highlights

Annamária Simó is associated with Egis Gyógyszergyár Rt., a prominent pharmaceutical company in Hungary. His role at the company has allowed him to engage in cutting-edge research and development, contributing to advancements in drug formulation and therapeutic strategies.

Collaborations

Throughout his career, Annamária has collaborated with esteemed colleagues, including László Balázs and József Barkóczy. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Annamária Simó's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His work continues to pave the way for new therapeutic options, showcasing the importance of research and collaboration in the advancement of healthcare solutions.